Skip to content
Home/ Ovarian Cancer Biomarkers: Mapping to Improve Outcomes (2021)
Ovarian Cancer Biomarkers: Mapping to Improve Outcomes (2021)

Ovarian Cancer Biomarkers: Mapping to Improve Outcomes (2021)

No customer reviews yet ISBN 9789811618758 Springer

Chapter 1. General Overview of the Origins and Pathology of Ovarian Cancer.- Chapter 2_An Introduction to the Current Management of Ovarian Cancer in the Era of Precision Oncology.- Chapter 3_The Hallmarks of Ovarian Cancer: Actionable Genetics, Targetable Pathways and Predictive Biomarkers.- Chapter 4_Genetic Alterations in Ovarian Cancer as Prognostic and Predictive Biomarkers of Therapy Response and Surgical Outcomes.- Chapter 5_The Emergence of Circulating Tumor DNA in the Management of Ovarian Cancer.- Chapter 6_Proteomic Biomarkers for Early Detection and Patients' Stratification in Ovarian Cancer.- Chapter 7_Cutting-edge Technologies and Ovarian Cancer.

About the author

Product details

BrandSpringer
Pub dateOct 10, 2022
ISBN-109811618755
ISBN-139789811618758
LanguageEnglish
Dimensions9.25 × 0.56 × 6.1 in
Weight1 lb
Last updated 2026-09-17 15:19
$125.03
In stock — ships in 24 hours with free tracking
Delivery by Wednesday, October 14, 2026
Qty
Sign in to Add to Saved list
Free delivery on orders over $35.
15-day returns. Any reason.
Secure checkout. We never store card details.

Readers who bought this also bought

More from Oncology - General
See all
Facing Cancer: A Complete Guide for People with Cancer, Their Families, and Caregivers
Stern, Theodore
$20.36
Cancer Pain Management
Fisch, Michael
$251.58
MD Anderson Manual of Psychosocial Oncology
Duffy, James D
$101.14
Gynecologic Oncology: Clinical Practice and Surgical Atlas
Karlan, Beth Y
$320.70
Harrison's Manual of Oncology
Chabner, Bruce a
$95.77
Advances in Cancer Research
Volume 68 of <b>Advances in Cancer Research</b> continues the tradition of publishing up-to-date reviews and "hot" topics in cancer research. This volume begins with a "Foundations in Cancer Research" article by Harald zur Hausen that reviews his years of research on the idea that cancer can be triggered by infection. The structure and function of the cytokine receptor superfamily and its association with leukemias are discussed in depth by James Ihle. Marcia Hall and Gordon Peters review the evidence indicating that genetic abnormalities hinder the function of certain cyclins and their inhibitors. The most widely studied protooncogene, c-<i>myc</i>, is reviewed by Marie Henriksson and Bernhard Lüscher&#x3b; the chapter focuses on the function of c-<i>myc</i> as a transcription factor rather than on the effects of gene translocation and activation on malignancies. Ham Werner and Derek LeRoith present data on the role that insulin-like growth factors play on cell growth and regulation. In the final chapter, Olli-P. Kallioniemi and Tapio Visakorpi investigate the field of prostate cancer and, more importantly, the biological reason and natural history behind the growth of this cancer.
$103.10